anxiety
NICE recommends nine digital treatment options for depression and anxiety
May 17, 2023Medical Communications NICE, Neurology, anxiety, depression, digital health, mental health
The National Institute for Health and Care Excellence (NICE) has recommended six digitally enabled therapies for adult patients with anxiety …
Seizures of black market diazepam tablets double in the UK in a year
December 5, 2019Manufacturing and Production Border Force, Diazepam, NHS, anxiety, opioids
The number of illegal diazepam tablets seized by the UK Border Force has doubled in a year, going from 545,000 …
Mylan issues recall for anxiety drug Xanax over contamination fears
October 29, 2019Manufacturing and Production Mylan, anxiety, pharma, xanax
Mylan has announced it has issued a recall of its anxiety therapy Xanax (alprazolam) over suspicions the drug could be …
England’s antidepressant prescriptions double to 70m in a decade
March 29, 2019Medical Communications England, UK, antidepressants, anxiety, depression, pharma
Figures released by NHS Digital have revealed that prescriptions for antidepressants in the UK have risen to 70.9 million, almost …
NHS talking therapies for mental health hit a high with 1.4 million referrals
December 5, 2017Manufacturing and Production, Medical Communications NHS, anxiety, depression, mental illness, pharma
New data has revealed that the number of UK patients seeking talking therapies on the NHS is on the rise, …
Five crucial facts about mental health
April 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, anxiety, depression, mental health, world health day
7 April marked this year’s World Health Day, and for 2017 the WHO selected depression as the annual focus. Prevalent …
Love it or hate it – Vitamin B12 may give the brain a boost
April 13, 2017Research and Development Marmite, anxiety, epilepsy
Trying to explain to someone outside of the UK or Australia and New Zealand what Marmite is can be a …
High Court rules against Pfizer in Lyrica patent case
September 10, 2015Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin
The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …
